Aldeyra Therapeutics Inc (ALDX)
4.135
-0.02
(-0.60%)
USD |
NASDAQ |
May 06, 16:00
4.135
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Cash from Financing (Quarterly): -1.012M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.012M |
| September 30, 2023 | -0.3158M |
| June 30, 2023 | 0.0053M |
| March 31, 2023 | 0.0526M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 1.197M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0233M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0638M |
| June 30, 2021 | 120.37M |
| March 31, 2021 | 74.06M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 26.22M |
| June 30, 2020 | 12.42M |
| March 31, 2020 | 3.253M |
| December 31, 2019 | 8.333M |
| September 30, 2019 | 14.84M |
| June 30, 2019 | -0.0091M |
| March 31, 2019 | 0.4076M |
| December 31, 2018 | 66.29M |
| September 30, 2018 | 1.113M |
| Date | Value |
|---|---|
| June 30, 2018 | 9.031M |
| March 31, 2018 | 4.093M |
| December 31, 2017 | 0.048M |
| September 30, 2017 | 26.83M |
| June 30, 2017 | -0.0297M |
| March 31, 2017 | 10.58M |
| December 31, 2016 | 0.0361M |
| September 30, 2016 | -0.1021M |
| June 30, 2016 | 12.81M |
| March 31, 2016 | -0.0097M |
| December 31, 2015 | -0.0142M |
| September 30, 2015 | -0.0362M |
| June 30, 2015 | 19.48M |
| March 31, 2015 | 9.039M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.1768M |
| June 30, 2014 | 10.28M |
| March 31, 2014 | -0.0528M |
| December 31, 2013 | 1.099M |
| September 30, 2013 | 1.938M |
| June 30, 2013 | -0.0417M |
| March 31, 2013 | 0.7504M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.012M
Minimum
Dec 2023
120.37M
Maximum
Jun 2021
13.66M
Average
0.0526M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| AbbVie Inc | 10.82B |
| United Therapeutics Corp | -1.068B |
| Heron Therapeutics Inc | 0.199M |
| Esperion Therapeutics Inc | 4.471M |
| FibroGen Inc | -0.246M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.5004M |
| Free Cash Flow | -30.33M |
| Free Cash Flow Per Share (Quarterly) | 0.0085 |
| Free Cash Flow Yield | -12.44% |